By leveraging offline reinforcement learning, where algorithms learn from patient records, researchers have achieved significant progress. This exciting development highlights the potential of learning from patients’ decisions, rather than relying on trial and error, to achieve optimal blood glucose control (
).
, a prevalent autoimmune condition in the UK, is characterized by insulin insufficiency, which plays a vital role in regulating blood glucose.
Selecting the correct insulin dose becomes an intricate and demanding task due to numerous factors that influence blood glucose levels. While current artificial pancreas devices automate insulin dosing, their decision-making algorithms remain simplistic and limited.
recently published a study that underscores the potential of offline reinforcement learning as a crucial milestone in diabetes care. Notably, children experience the most significant improvement, with additional one-and-a-half hours spent within the target glucose range each day.
This achievement is particularly noteworthy, as children often struggle to manage their diabetes independently, and such progress could significantly enhance their long-term health outcomes.
Unleashing the Power of Machine Learning
Lead author Harry Emerson, from the Department of Engineering Mathematics at Bristol, explains the study’s focus on investigating whether reinforcement learning can create safer and more effective insulin dosing strategies.
Advertisement
While machine learning algorithms have already exhibited superhuman performance in chess and self-driving cars, this research explores the potential of leveraging pre-collected blood glucose data to deliver highly personalized insulin dosing.
Offline Reinforcement Learning to Control Diabetes
The researchers emphasize the significance of offline reinforcement learning, in which the algorithm learns optimal actions by observing successful and unsuccessful blood glucose control examples. Unlike previous methods that rely on trial and error, this approach minimizes the risk of exposing real-world patients to unsafe insulin doses.
Rigorous Testing for Patient Safety
Due to the high stakes associated with incorrect insulin dosing, the experiments utilized the FDA-approved UVA/Padova simulator. This powerful tool creates a virtual patient cohort to rigorously test type 1 diabetes control algorithms.
Leading offline reinforcement learning algorithms were evaluated against a widely used artificial pancreas control algorithm. The comparison encompassed 30 virtual patients, including adults, adolescents, and children, and considered 7,000 days of data. Performance evaluation adhered to current clinical guidelines, while the simulator also accounted for realistic implementation challenges, such as measurement errors, incorrect patient information, and limited data availability.
Paving the Way for Future Research
This groundbreaking work lays the foundation for ongoing reinforcement learning research in glucose control. It highlights the immense potential of this approach to enhance the health outcomes of individuals with type 1 diabetes. Nevertheless, it also identifies areas that require further development and addresses the method’s limitations.
Aiming for Real-World Application
The researchers’ ultimate goal is to implement reinforcement learning in real-world artificial pancreas systems. These systems operate with minimal patient oversight, necessitating robust evidence of safety and effectiveness to obtain regulatory approval.
Harry emphasizes that this research showcases machine learning’s potential to learn effective insulin dosing strategies from pre-collected type 1 diabetes data. The explored method outperforms one of the most widely used commercial artificial pancreas algorithms. It demonstrates the ability to leverage a person’s habits and schedule to respond swiftly to dangerous events.
Reference :
- A Reinforcement Learning Based System for Blood Glucose Control without Carbohydrate Estimation in Type 1 Diabetes: In Silico Validation – (https:pubmed.ncbi.nlm.nih.gov/36086458/)
Source: Medindia
Source link
#SelfDriving #Car #Technology #Deliver #Insulin
